IL17A and Hepatic fibrosis: In vivo studies confirmed that activation of TLR3 in HSCs by exosomes derived from damaged hepatocytes exacerbates liver fibrosis by enhancing the production of chemokine (C-C motif) ligand 20 (CCL20) and interleukin-17A (IL-17A).